Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Julie Parmentier"'
Autor:
Emma Guttman-Yassky, Ana B. Pavel, Jonathan Silverberg, Stephan Weidinger, Julie Parmentier, Henrique D. Teixeira, Feng Hong, Lisa A. Beck, Bjoern Wolff
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 8, Pp 100429- (2020)
Externí odkaz:
https://doaj.org/article/c6e0bf13666347ae869ba05af90ad187
Autor:
Ross Stewart, Robert W. Wilkinson, Viia Valge-Archer, Rebecca Leyland, Jim Freeth, Geoffrey S. Williams, Ralph Minter, Jun Wang, Julie Parmentier, Steven Rust, Alan Sandercock, Chelsea Black, John Bradley, Jelena Jovanovic, Lutz Jermutus, Andrea L. Gonzalez-Munoz, Bina Mistry, Sandrine Guillard, Rafia S. Al-Lamki, Jane Coates Ulrichsen, Jo Soden, Vahe Bedian, Andrew J. Leishman
Publikováno v:
Oncotarget
Antibodies that target cell-surface molecules on T cells can enhance anti-tumor immune responses, resulting in sustained immune-mediated control of cancer. We set out to find new cancer immunotherapy targets by phenotypic screening on human regulator
Autor:
Emma Guttman-Yassky, Lisa A. Beck, Kristie M. Grebe, Feng Hong, Jonathan I. Silverberg, Julie Parmentier, Henrique D. Teixeira
Publikováno v:
Journal of Allergy and Clinical Immunology. 143:AB125
Publikováno v:
Public Health Nutr
ObjectiveTo investigate test–retest reliability of primary-school children's reports of food preferences and to investigate agreement with parental reports.DesignChildren completed an online test and retest, one to two weeks later, during school ho
Autor:
Edmund Poon, Robert W. Wilkinson, Andrew Buchanan, John S. Babcook, Ian Foltz, Michelle Morrow, Julie Parmentier, Vahe Bedian, Matthieu Chodorge, Matthew McCourt, Ross Stewart, Amanda Watkins, Marat Alimzhanov, David Bannister, Nicola Crawford, Kathy Mulgrew, John Andrews, Scott A. Hammond, Emily Dick, Danielle Marcus, Stefanie R. Mullins
Publikováno v:
Cancer immunology research. 3(9)
Programmed cell-death 1 ligand 1 (PD-L1) is a member of the B7/CD28 family of proteins that control T-cell activation. Many tumors can upregulate expression of PD-L1, inhibiting antitumor T-cell responses and avoiding immune surveillance and eliminat
Autor:
Melissa Passino, Kate Byth, Scott A. Ezell, Suprawee Tepsuporn, Michele Mayo, Julie Parmentier, Corinne Reimer, Shaun E. Grosskurth, Suping Wang, Teeru Bihani, Michael Collins
Publikováno v:
Oncotarget
Diffuse large B cell lymphoma is generally treated by chemotherapy and there is an unmet medical need for novel targeted therapies or combination therapies. Using in vitro screening, we have identified the combination of ibrutinib, an inhibitor of th
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 907
This chapter describes in vitro and in vivo methods to characterize a lead monoclonal antibody candidate in the drug discovery setting. Approaches to characterize monoclonal antibody specificity, heavy and light chain composition, and antibody mode o
Publikováno v:
Antibody Engineering ISBN: 9781617799730
This chapter describes in vitro and in vivo methods to characterize a lead monoclonal antibody candidate in the drug discovery setting. Approaches to characterize monoclonal antibody specificity, heavy and light chain composition, and antibody mode o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b598c95d45e3d93d4672efa09b99111d
https://doi.org/10.1007/978-1-61779-974-7_32
https://doi.org/10.1007/978-1-61779-974-7_32
Autor:
Pankaj Patil, Stephanos Ioannidis, Davies Audrey, Dennis Huszar, Nancy Su, Joseph M. Gozgit, Geraldine Bebernitz, Julie Parmentier, Tao Wang, Michael Zinda, Minwei Ye, Jiaquan Wu
Publikováno v:
The Journal of biological chemistry. 283(47)
The Janus-associated kinase 2 (JAK2) V617F mutation is believed to play a critical role in the pathogenesis of polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis. We have characterized a novel small molecule JAK2 inhibitor, AZ
Autor:
Sandrine Guillard, Amy Popple, Alan Sandercock, Andrea L. Gonzalez-Munoz, James Hair, Vahe Bedian, Geoff Williams, Ralph Minter, Ross Stewart, Arthur Lewis, Jacques Moissan, Bina Mistry, Julie Parmentier, Edmund Poon, Jane Coates Ulrichsen, Judith Anderton, Robert W. Wilkinson, Olivia Harris, Steve Rust, Andrew J. Leishman, Viia Valge-Archer
Publikováno v:
Cancer Research. 74:4613-4613
Regulatory T cells (Treg cells) are observed within multiple tumor types and contribute to immune evasion. Effective and specific targeting of Treg cells by antibodies is hampered by the lack of a unique surface marker. With the aim of identifying su